Epidemiology of chronic kidney disease in Australian general practice: National Prescribing Service MedicineWise MedicineInsight dataset

Nephrology - Tập 24 Số 10 - Trang 1017-1025 - 2019
Jan Radford1, Alex Kitsos1, Jim Stankovich1, Ronald L. Castelino2, Shandell Elmer1, Matthew Jose1, Gregory M. Peterson1, Timothy Saunder1, Tabish Razizaidi1
1School of Medicine, University of Tasmania, Launceston, Tasmania, Australia
2Sydney Nursing School, University of Sydney, Sydney, New South Wales, Australia

Tóm tắt

ABSTRACTAimTo describe sociodemographic characteristics and comorbidities of a large cohort of Australian general practice‐based patients identified as having chronic kidney disease (CKD), using data from National Prescribing Service (NPS) MedicineWise's MedicineInsight dataset, and compare this dataset to the 2011–2012 Australian Health Survey's (AHS) CKD prevalence estimates.MethodsThis was a cohort study using deidentified, longitudinal, electronic health record data collected from 329 practices and 1 483 416 patients distributed across Australia, from 1 June 2013 until 1 June 2016. Two methods were used to calculate the CKD prevalence. One used the same method as used by the 2011–2012 AHS, based on one estimate of the estimated glomerular filtration rate (eGFR) or albumin/creatinine ratios (ACR). The other defined CKD more rigorously using eGFR or ACR results at least 90 days apart.ResultsIn 2016, of 1 310 602 active patients, 710 674 (54.2%) did not have an eGFR or ACR test, while 524 961 (40.1%) had an eGFR or ACR test but did not meet AHS criteria for CKD. Age–sex adjusted rates of CKD (compared to AHS) were CKD 1–0.45% (3.9%), CKD 2–0.62% (2.5%), CKD 3a: 3.1% (2.7%), CKD 3b: 1.14% (0.6%), CKD 4–5: 0.41% (0.3%). The CKD cohort defined more rigorously using eGFR and ACR measures >90 days apart, had comorbidities of atrial fibrillation (30.5%), cardiovascular disease (25.0%), diabetes mellitus (17.1%) and hypertension (14.8%).ConclusionThe MedicineInsight dataset contains valuable and timely information about Australian patients with CKD, and provides prevalence estimates similar to those from AHS data.

Từ khóa


Tài liệu tham khảo

10.1371/journal.pone.0158765

10.1186/s12882-015-0189-z

Australian Bureau of Statistics.Australian Health Survey: Biomedical Results for Chronic Diseases 2011‐12‐Australia Canberra 2013.[Cited 26 Aug 2018.] Available from URL:http://www.abs.gov.au/ausstats/[email protected]/Lookup/4364.0.55.005Chapter4002011-12

Australian Bureau of Statistics, 2015, National Health Survey: First Results, 2014–15. Kidney disease

10.1111/1753-6405.12309

10.1093/ndt/gfw318

10.1001/jama.2017.2825

10.1080/00365510802144953

Britt H, 2015, General Practice Activity in Australia.

Harrison C, 2017, The prevalence of diagnosed chronic conditions and multimorbidity in Australia: A method for estimating population prevalence from general practice patient encounter data, PLoS One, 3

10.1186/1471-2458-14-557

10.1186/s12891-018-1941-x

NPS MedicineWise. MedicineInsight Sydney Surry Hills NSW: NPS MedicineWise;2017. Available from URL:https://www.nps.org.au/medicine-insight

Royal Australian College of General Practitioners, 2017, Standards for General Practice : Glossary of Terms: Active Patient

10.1111/j.1523-1755.2005.00365.x

Kidney Health Australia, 2015, Chronic Kidney Disease (CKD) Management in General Practice

10.7326/0003-4819-150-9-200905050-00006

MedicineInsight, 2016, MedicineInsight Data Book Version 1.2.

MedicineInsight, 2018, MedicineInsight Data Book version 1.1.

Jensen OM, 1991, Cancer Registration: Principles and Methods

Australian Bureau of Statistics, 2016, Australian Demographic Statistics Jun 2016

Australian Bureau of Statistics, 2018, Australian Statistical Geography Standard (ASGS)

2013, Australian Bureau of Statistics Technical paper : Socio‐Economic Indexes for Areas (SEIFA).

10.1186/s12882-017-0607-5

10.1111/jgs.14662

10.5694/mja16.00528

Anstey M, 2017, Realising the Potential of Health Needs Assessments

10.5694/mja12.11028